The interaction in the vessels of SARS-CoV-2 patients of monocytes (CD61−) and platelets (CD61+) is responsible for hypercoagulation, thrombosis, and Disseminated Intravascular Coagulation (DIC)—a late event associated with lethality (Figure 1c–e). This evidence concerns the gene ITGB3 and deep vein thrombosis.